Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1393 Discovery of PLX-4107, a selective IKZF2 molecular glue degrader, that modulates suppressive regulatory T cells and demonstrates anti-tumor activity
Compose a Response to This Article
Other responses
No responses have been published for this article.
